A detailed history of Fny Investment Advisers, LLC transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 28,750 shares of IMMX stock, worth $55,775. This represents 0.03% of its overall portfolio holdings.

Number of Shares
28,750
Holding current value
$55,775
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$1.38 - $2.54 $39,675 - $73,025
28,750 New
28,750 $63,000
Q2 2024

Aug 05, 2024

BUY
$1.81 - $3.06 $12,670 - $21,420
7,000 Added 27.45%
32,500 $64,000
Q1 2024

May 02, 2024

BUY
$2.64 - $6.68 $67,320 - $170,340
25,500 New
25,500 $78,000

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $27M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.